DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $70,925,000 | +7.0% | 496,255 | -1.2% | 1.47% | +0.3% |
| Q1 2019 | $66,285,000 | +27.6% | 502,082 | -0.3% | 1.47% | +4.0% |
| Q4 2018 | $51,953,000 | -5.8% | 503,809 | -0.8% | 1.41% | +26.6% |
| Q3 2018 | $55,169,000 | +10.5% | 507,725 | +0.4% | 1.11% | +1.2% |
| Q2 2018 | $49,920,000 | +1.4% | 505,878 | +0.6% | 1.10% | -3.7% |
| Q1 2018 | $49,218,000 | +19.2% | 502,687 | +13.0% | 1.14% | +21.7% |
| Q4 2017 | $41,304,000 | +7.4% | 444,995 | -0.8% | 0.94% | -0.8% |
| Q3 2017 | $38,472,000 | -36.2% | 448,491 | -37.2% | 0.95% | -37.8% |
| Q2 2017 | $60,299,000 | +5.0% | 714,531 | +6.5% | 1.52% | +1.3% |
| Q1 2017 | $57,406,000 | +12.9% | 671,183 | +2.7% | 1.50% | +3.4% |
| Q4 2016 | $50,857,000 | +1.1% | 653,356 | +1.8% | 1.45% | -1.4% |
| Q3 2016 | $50,307,000 | -20.8% | 641,755 | +2.1% | 1.47% | -24.8% |
| Q2 2016 | $63,494,000 | +9.3% | 628,657 | +2.6% | 1.96% | -27.7% |
| Q1 2016 | $58,115,000 | +6.8% | 612,636 | +4.5% | 2.71% | +8.8% |
| Q4 2015 | $54,436,000 | +12.0% | 586,088 | +2.8% | 2.49% | +13.9% |
| Q3 2015 | $48,589,000 | +2.6% | 570,221 | +3.1% | 2.19% | +20.3% |
| Q2 2015 | $47,341,000 | +68.4% | 553,113 | +67.0% | 1.82% | +61.2% |
| Q1 2015 | $28,117,000 | -0.4% | 331,181 | +0.5% | 1.13% | -2.7% |
| Q4 2014 | $28,242,000 | +15.1% | 329,506 | +2.0% | 1.16% | +3.5% |
| Q3 2014 | $24,533,000 | -41.2% | 322,894 | -39.1% | 1.12% | -40.2% |
| Q2 2014 | $41,750,000 | -17.9% | 530,293 | -21.8% | 1.87% | +82.8% |
| Q1 2014 | $50,831,000 | +99.9% | 677,746 | +105.8% | 1.02% | -15.9% |
| Q4 2013 | $25,429,000 | +11.7% | 329,387 | +0.3% | 1.22% | +3.7% |
| Q3 2013 | $22,763,000 | +7.6% | 328,381 | -1.8% | 1.18% | +11.4% |
| Q2 2013 | $21,158,000 | – | 334,255 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |